Prosecution Insights
Last updated: July 05, 2026
Application No. 17/994,826

SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR TRANSCRANIAL MAGNETIC STIMULATION TREATMENT OF NEUROPSYCHIATRIC DISORDERS

Non-Final OA §101
Filed
Nov 28, 2022
Priority
May 28, 2020 — provisional 63/031,287 +1 more
Examiner
HOANG, HAN DINH
Art Unit
2661
Tech Center
2600 — Communications
Assignee
Research Foundation For Mental Hygiene Inc.
OA Round
2 (Non-Final)
74%
Grant Probability
Favorable
2-3
OA Rounds
0m
Est. Remaining
93%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allowance Rate
128 granted / 174 resolved
+11.6% vs TC avg
Strong +20% interview lift
Without
With
+19.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
19 currently pending
Career history
197
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
94.8%
+54.8% vs TC avg
§102
1.7%
-38.3% vs TC avg
§112
1.3%
-38.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 174 resolved cases

Office Action

§101
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Double Patenting A rejection based on double patenting of the “same invention” type finds its support in the language of 35 U.S.C. 101 which states that “whoever invents or discovers any new and useful process... may obtain a patent therefor...” (Emphasis added). Thus, the term “same invention,” in this context, means an invention drawn to identical subject matter. See Miller v. Eagle Mfg. Co., 151 U.S. 186 (1894); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Ockert, 245 F.2d 467, 114 USPQ 330 (CCPA 1957). A statutory type (35 U.S.C. 101) double patenting rejection can be overcome by canceling or amending the claims that are directed to the same invention so they are no longer coextensive in scope. The filing of a terminal disclaimer cannot overcome a double patenting rejection based upon 35 U.S.C. 101. Claims 1-2, 4, 7-18, 20-23, 43 and 64-67 are rejected under 35 U.S.C. 101 as claiming the same invention as that of claims 1-28 of prior U.S. Patent No. 11779218. This is a statutory double patenting rejection. All of the independent claims in the present application are verbatim and substantially similar to the independent claims in U.S. Patent No. 11779218. The main difference being the present application uses the term “patient” in all of the independent claims and the U.S. Patent No. 11779218 uses the term “subject”. This difference is not enough to overcome a statutory double patenting as the terms are interchangeable when read in light of the specification. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to HAN D HOANG whose telephone number is (571)272-4344. The examiner can normally be reached Monday-Friday 8-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, JOHN M VILLECCO can be reached at 571-272-7319. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /HAN HOANG/Primary Examiner, Art Unit 2661
Read full office action

Prosecution Timeline

Nov 28, 2022
Application Filed
Jun 10, 2025
Non-Final Rejection mailed — §101
Sep 08, 2025
Response Filed
Sep 22, 2025
Examiner Interview (Telephonic)
Jan 08, 2026
Response after Non-Final Action
May 19, 2026
Non-Final Rejection mailed — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12670707
MACHINE LEARNING ENABLED SYSTEM FOR SKIN ABNORMALITY INTERVENTIONS
2y 11m to grant Granted Jun 30, 2026
Patent 12670688
METHODS, SYSTEMS, AND MEDIA FOR NAVIGATING VIDEO CONTENT
2y 4m to grant Granted Jun 30, 2026
Patent 12646289
VISUAL GROUNDING OF SELF-SUPERVISED REPRESENTATIONS FOR MACHINE LEARNING MODELS UTILIZING DIFFERENCE ATTENTION
2y 11m to grant Granted Jun 02, 2026
Patent 12633099
FINE-TUNING AND CONTROLLING DIFFUSION MODELS
3y 5m to grant Granted May 19, 2026
Patent 12633084
ELECTRONIC DEVICE FOR GENERATING DESCRIPTOR FOR FEATURE POINT, AND OPERATION METHOD THEREOF
2y 6m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
74%
Grant Probability
93%
With Interview (+19.6%)
2y 11m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 174 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month